Coenzyme Q10. Available at: PubChem
Injectable Wellness Boosters: Vitamin B12
This becomes problematic because patients become dehydrated from not drinking, which harms kidney function
Current head-to-head evidence suggests tirzepatide may produce greater average weight loss than semaglutide
The ADA/EASD consensus on glycaemic management algorithm already includes GLP-1 receptor agonists with cardiovascular benefit as an option for people with CKD when SGLT2 inhibitors are contraindicated or not tolerated, in order to reduce the risk of cardiovascular disease (Davies et al, 2022)
These include signs of severe hypoglycaemia such as confusion, difficulty speaking, loss of consciousness, seizures, or inability to swallow safely